Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150706> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- Q64150706 description "clinical trial" @default.
- Q64150706 description "ensayu clínicu" @default.
- Q64150706 description "klinisch onderzoek" @default.
- Q64150706 description "клінічне випробування" @default.
- Q64150706 name "Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea" @default.
- Q64150706 type Item @default.
- Q64150706 label "Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea" @default.
- Q64150706 prefLabel "Treatment Registry of Alectinib in Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer in Korea" @default.
- Q64150706 P1132 Q64150706-ABEA570B-35C4-44B6-959A-7A3F3B31BBFF @default.
- Q64150706 P1476 Q64150706-433D59DD-3B44-4EBC-9A9D-DF5E5B041D84 @default.
- Q64150706 P2899 Q64150706-43E40568-FF71-4112-A500-8E5B8A46090D @default.
- Q64150706 P3098 Q64150706-B9F349FB-0192-46D9-9627-7F4C1DAD1746 @default.
- Q64150706 P31 Q64150706-6B843FCD-E52B-4F83-9046-8ADB1EB51B4E @default.
- Q64150706 P580 Q64150706-53E5D051-9300-4B8F-9B91-CFCE8C2C6581 @default.
- Q64150706 P582 Q64150706-7F8E5ACD-546B-4AE2-AFEC-DF55CF99B98F @default.
- Q64150706 P6153 Q64150706-0AB08CDB-DD4C-40CB-B245-645E170EDCAC @default.
- Q64150706 P6153 Q64150706-13D65AB3-E3F8-4804-9102-AE3848238FF1 @default.
- Q64150706 P6153 Q64150706-148FAB2C-800F-4AC6-85C5-D26E45394B63 @default.
- Q64150706 P6153 Q64150706-3A225B68-9BBD-4873-BC65-C82AA8F1F5D2 @default.
- Q64150706 P6153 Q64150706-3FB36606-3A8E-4EF5-90BA-041D7EFF40BC @default.
- Q64150706 P6153 Q64150706-4D8FC54F-B4F8-49FE-A494-71663CD36D42 @default.
- Q64150706 P6153 Q64150706-6AA95140-14DF-4836-9D0B-C7C4336B0A82 @default.
- Q64150706 P6153 Q64150706-7068ED6D-77B0-47FA-9EAD-02F175A31827 @default.
- Q64150706 P6153 Q64150706-94C684DB-4FE1-4A29-8355-A015F7B81648 @default.
- Q64150706 P6153 Q64150706-A787149A-D63E-4822-8091-6F6797D49092 @default.
- Q64150706 P6153 Q64150706-B23285BC-2373-4B88-B1D4-4A7F0C598A79 @default.
- Q64150706 P6153 Q64150706-BFBAC776-21F4-45F6-9A33-55D12AF4D3A2 @default.
- Q64150706 P6153 Q64150706-C86E6919-1055-4D6B-9F50-1E3BEC5F5A6B @default.
- Q64150706 P6153 Q64150706-CEEC1649-6871-49E5-9B9B-9F34EAC984D1 @default.
- Q64150706 P6153 Q64150706-D3C3AAF0-8387-4015-B664-51624F63EC39 @default.
- Q64150706 P6153 Q64150706-E350E31E-A1A0-4DC1-BEBE-6E11764A258D @default.
- Q64150706 P6153 Q64150706-EEDF0DAC-34C9-4DFE-A9A9-31EFEAC17BBA @default.
- Q64150706 P8363 Q64150706-44F5F080-BBF6-4B6C-93CA-94E322A346F2 @default.
- Q64150706 P859 Q64150706-FC7A822B-DE70-4E5B-AD9C-D65387A5518A @default.
- Q64150706 P1132 "+167" @default.
- Q64150706 P1476 "Treatment Registry of Alecensa in Korean Patients With Anaplastic Lymphoma Kinase (ALK)-Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer" @default.
- Q64150706 P2899 "+19" @default.
- Q64150706 P3098 "NCT03271554" @default.
- Q64150706 P31 Q30612 @default.
- Q64150706 P580 "2017-11-09T00:00:00Z" @default.
- Q64150706 P582 "2020-10-29T00:00:00Z" @default.
- Q64150706 P6153 Q12591204 @default.
- Q64150706 P6153 Q139779 @default.
- Q64150706 P6153 Q16188802 @default.
- Q64150706 P6153 Q30253976 @default.
- Q64150706 P6153 Q30262810 @default.
- Q64150706 P6153 Q30280617 @default.
- Q64150706 P6153 Q30296168 @default.
- Q64150706 P6153 Q39988 @default.
- Q64150706 P6153 Q39997 @default.
- Q64150706 P6153 Q43896363 @default.
- Q64150706 P6153 Q4803501 @default.
- Q64150706 P6153 Q489488 @default.
- Q64150706 P6153 Q496536 @default.
- Q64150706 P6153 Q5587391 @default.
- Q64150706 P6153 Q623851 @default.
- Q64150706 P6153 Q624119 @default.
- Q64150706 P6153 Q626783 @default.
- Q64150706 P8363 Q818574 @default.
- Q64150706 P859 Q212646 @default.